Patients with lepromatous leprosy had a non-significant trend (p = 0.16) of decreasing CCL17 levels (Figure 5A) and a significant trend (p = 0.036) of increasing CCL18 (Figure 5B) levels in the serum. This evidence concerns the gene CCL17 and lepromatous leprosy.